NANO-OJAS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 18 May 2023)
What this means for you
Registered since 20 Dec 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87073835
- Registration number
- 5105133
- Mark type
- Stylized text
- Filed
- 16 Jun 2016
- Published for opposition
- 04 Oct 2016
- Registered
- 20 Dec 2016
- Attorney of record
- Scott D. Locke
Goods and services
- Class 005 — Pharmaceuticals: Analgesic and muscle relaxant nutraceutical preparations; Anti-diabetic nutraceuticals; Cardiovascular nutraceuticals; Nutraceutical preparations for the treatment of gout; Nutraceutical preparations and substances for the treatment of gastro-intestinal diseases; Nutraceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Nutraceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Nutraceutical preparations for inhalation for the treatment of pulmonary hypertension; Nutraceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Nutraceutical preparations for the treatment of inflammatory disorders; Nutraceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Nutraceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Nutraceutical preparations for the prevention of diabetes; Nutraceutical preparations for the treatment of eye diseases and conditions; Nutraceutical preparations for the treatment of heart rhythm disorders; Nutraceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Nutraceutical preparations for the treatment of infectious diseases; Nutraceutical preparations for the treatment of hypertension; Nutraceutical preparations for treating allergic rhinitis and asthma; Nutraceutical preparations for treating diabetes; Nutraceutical preparations for treating skin disorders; Nutraceutical preparations for use in urology; Nutraceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Nutraceutical products for ophthalmological use; Nutraceutical products for the treatment of bone diseases; Nutraceutical products for the treatment of joint disease; Nutraceutical products for the treatment of viral and infectious diseases; Nutraceutical preparations for the treatment of cancer; Nutraceutical products for treating respiratory diseases and asthma; Nutraceutical solutions used in dialysis; Nutraceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and nutraceutical purposes; Therapeutic nutraceuticals for the treatment of obesity
Owner
- NANORX INC., Chappaqua, NY, US
- NANORX INC., Chappaqua, NY, US
- NANORX INC., Chappaqua, NY, US
Prior registrations
Prosecution history
- 20 Dec 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 18 May 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 May 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 May 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Nov 2022 — TEAS SECTION 8 & 15 RECEIVED
- 20 Dec 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Dec 2016 — REGISTERED-PRINCIPAL REGISTER
- 05 Oct 2016 — POST PUBLICATION AMENDMENT - ENTERED
- 04 Oct 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Oct 2016 — PUBLISHED FOR OPPOSITION
- 04 Oct 2016 — ASSIGNED TO EXAMINER
- 27 Sept 2016 — ASSIGNED TO PETITION STAFF
- 15 Sept 2016 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 14 Sept 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Aug 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED